NO974313L - Hydrokinon-derivat og farmasöytisk bruk derav - Google Patents

Hydrokinon-derivat og farmasöytisk bruk derav

Info

Publication number
NO974313L
NO974313L NO974313A NO974313A NO974313L NO 974313 L NO974313 L NO 974313L NO 974313 A NO974313 A NO 974313A NO 974313 A NO974313 A NO 974313A NO 974313 L NO974313 L NO 974313L
Authority
NO
Norway
Prior art keywords
group
hydrogen atom
alkyl group
oxo
hydroquinone derivative
Prior art date
Application number
NO974313A
Other languages
English (en)
Other versions
NO313413B1 (no
NO974313D0 (no
Inventor
Yoshiaki Isobe
Yuso Goto
Masanori Tobe
Osamu Takahashi
Original Assignee
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp filed Critical Japan Energy Corp
Publication of NO974313D0 publication Critical patent/NO974313D0/no
Publication of NO974313L publication Critical patent/NO974313L/no
Publication of NO313413B1 publication Critical patent/NO313413B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19974313A 1996-09-19 1997-09-18 Hydrokinonderivat, anvendelse derav og farmasöytisk preparat NO313413B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24827296 1996-09-19

Publications (3)

Publication Number Publication Date
NO974313D0 NO974313D0 (no) 1997-09-18
NO974313L true NO974313L (no) 1998-03-20
NO313413B1 NO313413B1 (no) 2002-09-30

Family

ID=17175664

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974313A NO313413B1 (no) 1996-09-19 1997-09-18 Hydrokinonderivat, anvendelse derav og farmasöytisk preparat

Country Status (13)

Country Link
US (2) US5821247A (no)
EP (1) EP0831092B1 (no)
AT (1) ATE194838T1 (no)
AU (1) AU716992B2 (no)
CA (1) CA2216288C (no)
DE (1) DE69702580T2 (no)
DK (1) DK0831092T3 (no)
ES (1) ES2149548T3 (no)
GR (1) GR3034418T3 (no)
NO (1) NO313413B1 (no)
NZ (1) NZ328769A (no)
PT (1) PT831092E (no)
ZA (1) ZA978413B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523958A (ja) * 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−2の阻害剤、組成物ならびに使用法
EP1541562A4 (en) * 2002-09-20 2006-11-15 Dainippon Sumitomo Pharma Co NEW URACIL DERIVATIVES AND THEIR MEDICAL USE
PL2220030T3 (pl) 2007-11-06 2016-07-29 Bioelectron Tech Corp Pochodne 4-(p-chinonylo)-2-hydroksybutanamidu do leczenia chorób mitochondrialnych
HUE058877T2 (hu) 2014-12-16 2022-09-28 Ptc Therapeutics Inc (R)-2-hidroxi-2-metil-4-(2,4,5-trimetil-3,6-dioxociklohexa-1,4-dienil)butánamid polimorf és amorf alakjai
ES3033538T3 (en) * 2015-10-08 2025-08-05 Khondrion Ip B V Novel compounds for treating mitochondrial disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof

Also Published As

Publication number Publication date
DK0831092T3 (da) 2000-10-16
EP0831092A3 (en) 1998-04-08
PT831092E (pt) 2000-10-31
US5877318A (en) 1999-03-02
NO313413B1 (no) 2002-09-30
CA2216288C (en) 2006-02-07
CA2216288A1 (en) 1998-03-19
EP0831092B1 (en) 2000-07-19
ATE194838T1 (de) 2000-08-15
AU3760197A (en) 1998-03-26
GR3034418T3 (en) 2000-12-29
NO974313D0 (no) 1997-09-18
EP0831092A2 (en) 1998-03-25
ES2149548T3 (es) 2000-11-01
DE69702580T2 (de) 2001-03-08
ZA978413B (en) 1998-03-26
DE69702580D1 (de) 2000-08-24
AU716992B2 (en) 2000-03-16
US5821247A (en) 1998-10-13
NZ328769A (en) 1998-07-28

Similar Documents

Publication Publication Date Title
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
EP1253142A4 (en) COMPOUNDS HAVING AGONISM AGAINST THE THROMBOPOIETIN RECEPTOR
DE69533277D1 (de) Dc-89 derivat
CA2234096A1 (en) 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
EP0955293A4 (en) NEW UREA DERIVATIVES
WO2001072728A3 (en) Novel piperazine derivatives
CA2206532A1 (en) Novel amidinonaphthyl derivative or salt thereof
ATE306261T1 (de) Antithrombosemittel
CA2219675A1 (en) Pentacyclic compound
WO2002032901A3 (en) Bridged piperazine derivatives
NO995638L (no) Heterobicykliske forbindelser til fremstilling av pyridonkarboksylsyrederivater
EP0292576A4 (en) Anti-ulcerous agent containing chalcone derivative as effective ingredient and novel chalcone derivatives
NO974313D0 (no) Hydrokinon-derivat og farmasöytisk bruk derav
ES2093091T3 (es) Derivado de glutation.
MX9606523A (es) Derivados del acido fosfonico.
ATE192447T1 (de) Camptothecin-derivate, ihre herstellung und antitumormittel
CA2262997A1 (en) Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
EP0315434A3 (en) Pyridoxal hydrazone derivatives their production and use and pharmaceutical compositions containing the same
IL127687A0 (en) The preparation of 3-pyrroline-2-carboxylic acid derivatives
ES2151442B1 (es) Nuevo derivado del bencenoetanol.
EP0997463A4 (en) NAPHTHYRIDINE DERIVATIVES
IT1255207B (it) Composizioni farmaceutuche ad attivita' antiaggregante e vasodilatatrice
BG102429A (en) Derivatives of 5-naphthalen-1-yl-1,3-dioxan, their preparation and usage as therapeutical means
ES479928A1 (es) Un procedimiento para la preparacion de derivados de 6,7-ben-zomorfan.
EP1048649A4 (en) 5-ARYLPYRROL DERIVATIVES